These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 27216742)

  • 1. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer.
    Vila J; Mittendorf EA; Farante G; Bassett RL; Veronesi P; Galimberti V; Peradze N; Stauder MC; Chavez-MacGregor M; Litton JF; Huo L; Kuerer HM; Hunt KK; Caudle AS
    Ann Surg Oncol; 2016 Oct; 23(11):3501-3509. PubMed ID: 27216742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer.
    Schipper RJ; Moossdorff M; Nelemans PJ; Nieuwenhuijzen GA; de Vries B; Strobbe LJ; Roumen RM; van den Berkmortel F; Tjan-Heijnen VC; Beets-Tan RG; Lobbes MB; Smidt ML
    Clin Breast Cancer; 2014 Oct; 14(5):315-22. PubMed ID: 24548732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy.
    Barron AU; Hoskin TL; Boughey JC
    Ann Surg Oncol; 2018 Oct; 25(10):2867-2874. PubMed ID: 29956095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram Based on US and Clinicopathologic Characteristics: Axillary Nodal Evaluation Following Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer.
    Huang JX; Chen YJ; Wang XY; Huang JH; Gan KH; Tang LN; Pei XQ
    Clin Breast Cancer; 2024 Aug; 24(6):e452-e463.e4. PubMed ID: 38580573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer.
    Kim JY; Park HS; Kim S; Ryu J; Park S; Kim SI
    Medicine (Baltimore); 2015 Oct; 94(43):e1720. PubMed ID: 26512562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases.
    Guo R; Su Y; Si J; Xue J; Yang B; Zhang Q; Chi W; Chen J; Chi Y; Shao Z; Wu J
    Cancer; 2020 Aug; 126 Suppl 16():3819-3829. PubMed ID: 32710664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer.
    Kantor O; Sipsy LM; Yao K; James TA
    Ann Surg Oncol; 2018 May; 25(5):1304-1311. PubMed ID: 29368152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer.
    Murphy BL; L Hoskin T; Heins CDN; Habermann EB; Boughey JC
    Ann Surg Oncol; 2017 Sep; 24(9):2518-2525. PubMed ID: 28484921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory indicators predict axillary nodal pathologic complete response after neoadjuvant therapy in breast cancer.
    Chen P; Zhao T; Bi Z; Zhang ZP; Xie L; Liu YB; Song XG; Song XR; Wang CJ; Wang YS
    Future Oncol; 2021 Jul; 17(19):2449-2460. PubMed ID: 33878939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and external validation.
    Zheng Q; Yan H; He Y; Wang J; Zhang N; Huo L; Liu Y; Wang L; Xu L; Fan Z
    Cancer; 2024 Apr; 130(S8):1513-1523. PubMed ID: 38427584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients.
    Jin X; Jiang YZ; Chen S; Shao ZM; Di GH
    Sci Rep; 2016 Aug; 6():32585. PubMed ID: 27576704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of neoadjuvant chemotherapy on pathologic axillary nodal status in HER-2 positive patients presenting with clinically node-negative disease.
    Al-Hilli Z; Hieken TJ; Hoskin TL; Heins CN; Boughey JC
    J Surg Oncol; 2015 Oct; 112(5):453-7. PubMed ID: 26345596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.
    Mamtani A; Barrio AV; King TA; Van Zee KJ; Plitas G; Pilewskie M; El-Tamer M; Gemignani ML; Heerdt AS; Sclafani LM; Sacchini V; Cody HS; Patil S; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3467-3474. PubMed ID: 27160528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms for preoperative prediction of axillary nodal status in breast cancer.
    Dihge L; Bendahl PO; Rydén L
    Br J Surg; 2017 Oct; 104(11):1494-1505. PubMed ID: 28718896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy.
    Maimaitiaili A; Chen H; Xie P; Liu Z; Ling R; Zhao Y; Yang H; Liu Y; Liu K; Zhang J; Mao D; Yu Z; Liu Y; Fu P; Wang J; Jiang H; Zhao Z; Tian X; Cao Z; Wu K; Song A; Jin F; He J; Fan Z; Zhang H
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8769-8778. PubMed ID: 37129606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Loss of Lymph Node Metastases After Neoadjuvant Chemotherapy in Patients With Cytology-proven Axillary Node-positive Primary Breast Cancer.
    Namura M; Tsunoda H; Kobayashi D; Enokido K; Yoshida A; Watanabe T; Suzuki K; Nakamura S; Yamauchi H; Hayashi N
    Clin Breast Cancer; 2019 Aug; 19(4):278-285. PubMed ID: 30975473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
    Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
    Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.
    Ryu JM; Lee SK; Kim JY; Yu J; Kim SW; Lee JE; Han SH; Jung YS; Nam SJ
    Clin Breast Cancer; 2017 Nov; 17(7):550-558. PubMed ID: 28454926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST).
    Liedtke C; Kolberg HC; Kerschke L; Görlich D; Bauerfeind I; Fehm T; Fleige B; Helms G; Lebeau A; Stäbler A; Schmatloch S; Hausschild M; Schwentner L; von Minckwitz G; Loibl S; Untch M; Kühn T
    Clin Exp Metastasis; 2018 Dec; 35(8):777-783. PubMed ID: 30324492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy.
    Petruolo OA; Pilewskie M; Patil S; Barrio AV; Stempel M; Wen HY; Morrow M
    Ann Surg Oncol; 2017 Sep; 24(9):2556-2562. PubMed ID: 28560596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.